Arm vs. Taiwan Semiconductor Manufacturing: Which Chip Stock Is a Better Buy in 2026?

TSMC is favored over Arm on materially stronger profitability, AI-chip manufacturing indispensability, and a lower valuation: TSMC trades at 25.8x forward P/E and 18.6x sales, versus Arm at 123.7x and 59.8x, respectively. TSMC generated $121.3B of FY2025 revenue (+33% YoY), $54.7B of net income (45.1% margin), and $34.6B of free cash flow; its Q2 net income nearly doubled and management raised its full-year outlook. Arm delivered FY2026 revenue of roughly $4.9B (+22.8%) and $904M of net income, but faces RISC-V and custom-chip competition alongside a substantially richer valuation. TSMC's principal risk remains geopolitical exposure from its Taiwan manufacturing concentration and high capital-intensity requirements.

Analysis

The investable distinction is operating leverage versus valuation duration. TSM monetizes each incremental leading-edge wafer through both volume and pricing, while ARM must prove that higher-value compute royalties can grow fast enough to justify a valuation that leaves little room for licensing-mix or customer-adoption slippage. ARM's stock-based-compensation burden is especially important: per-share FCF compounding will lag reported cash generation unless dilution moderates, creating a likely multiple-compression trigger at the next earnings cycle.

A long TSM/short ARM pair expresses AI compute growth while isolating the more fragile assumption: that IP economics deserve a materially higher terminal multiple than scarce manufacturing capacity. Over 1-3 months, TSM upside depends on sustained advanced-packaging utilization, pricing discipline, and customer capex; ARM needs a material royalty-rate and data-center mix inflection, not merely unit growth. The structural 6-18 month beneficiary is also TSM's packaging ecosystem: bottlenecks in CoWoS-like capacity can transfer economics from GPU designers to the foundry rather than expand semiconductor-wide margins.

The consensus risk to the TSM preference is not Intel or Samsung competition, but Taiwan-risk repricing occurring independently of fundamentals; a geopolitical headline can overwhelm a favorable earnings revision cycle within days. Conversely, ARM is a potential contrarian long only if evidence shows custom AI silicon broadening its royalty pool faster than expected, since lower-cost RISC-V adoption is more threatening in commodity/edge categories than in performance-sensitive mobile and server designs. A meaningful ARM upside thesis requires disclosed evidence of rising royalty revenue per chip and containment of share-count growth.

Key Decisions for Investors

• Initiate a 3-6 month relative-value position: long TSM / short ARM in roughly dollar-neutral sizing. Target a 15-25% narrowing in the valuation premium through TSM estimate revisions and ARM multiple normalization; exit if ARM reports a clear acceleration in data-center royalty mix plus materially lower dilution, or if TSM cuts capex/advanced-node demand commentary.
• For outright TSM exposure, buy shares on post-earnings or Taiwan-headline pullbacks rather than chase strength; pair with 6-month out-of-the-money TSM puts to cap event risk. The hedge is essential because geopolitical risk can produce a discontinuous drawdown that earnings strength will not offset.
• Monitor TSM advanced packaging capacity, utilization, and gross-margin guidance as the highest-frequency confirmation signals. A utilization decline or margin guide-down would invalidate the thesis before reported revenue weakness, and would also pressure NVDA and AMD through potential AI-system shipment constraints.
• Avoid adding to ARM solely on headline AI enthusiasm. Upgrade to a long only after management demonstrates sustained royalty-per-unit expansion and share-count discipline; absent that evidence, ARM is better used as the short leg against TSM than as a standalone short given its scarcity premium and potential custom-silicon upside.